Jiangxi Fushine Pharmaceutical Plans to Increase VC Product Capacity to 10,000 Tons/Year Through Technical Upgrades, Expected Completion by Q2 2026

Deep News
2025/11/16

Jiangxi Fushine Pharmaceutical Co., Ltd. (300497.SZ) disclosed in its investor relations activity report that, according to Wind data, the price of VC products has remained around RMB 50,000 per ton over the past two years. Recently, VC prices have surged rapidly, driven by strong demand growth in energy storage batteries, power batteries, as well as macroeconomic policies and industry supply-demand dynamics.

Currently, the company has an annual production capacity of 8,000 tons for VC products and approximately 4,000 tons for FEC products. It plans to expand VC production capacity to 10,000 tons per year through technical upgrades, with the project expected to be completed by the second quarter of 2026. Depending on market demand and industry capacity expansion, the company may further increase VC and FEC production capacities to 20,000 tons and 5,000 tons per year, respectively.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10